首页 > 最新文献

Circulation. Cardiovascular Quality and Outcomes最新文献

英文 中文
Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study. 急性心肌梗死后并发肥胖和营养不良患者的长期预后:一项队列研究。
IF 6.9 2区 医学 Pub Date : 2023-04-01 DOI: 10.1161/CIRCOUTCOMES.122.009340
Gwyneth Kong, Audrey Zhang, Bryan Chong, Jieyu Lim, Shankar Kannan, Yip Han Chin, Cheng Han Ng, Chaoxing Lin, Chin Meng Khoo, Mark Muthiah, Mayank Dalakoti, William Kristanto, Yibin Wang, William Kong, Kian Keong Poh, Ping Chai, Roger Foo, Mark Yan-Yee Chan, Poay-Huan Loh, Nicholas W S Chew

Background: The double burden of malnutrition, described as the coexistence of malnutrition and obesity, is a growing global health issue. This study examines the combined effects of obesity and malnutrition on patients with acute myocardial infarction (AMI).

Methods: Patients presenting with AMI to a percutaneous coronary intervention-capable hospital in Singapore between January 2014 and March 2021 were retrospectively studied. Patients were stratified into the following: (1) nourished nonobese, (2) malnourished nonobese, (3) nourished obese, and (4) malnourished obese. Obesity and malnutrition were defined according to the World Health Organization definition (body mass index ≥27.5 kg/m2) and Controlling Nutritional Status score, respectively. The primary outcome was all-cause mortality. The association between combined obesity and nutritional status with mortality was examined using Cox regression, adjusted for age, sex, AMI type, previous AMI, ejection fraction, and chronic kidney disease. Kaplan-Meier curves for all-cause mortality were constructed.

Results: The study included 1829 AMI patients, of which 75.7% were male and mean age was 66 years. Over 75% of patients were malnourished. Majority were malnourished nonobese (57.7%), followed by malnourished obese (18.8%), nourished nonobese (16.9%), and nourished obese (6.6%). Malnourished nonobese had highest all-cause mortality (38.6%), followed by the malnourished obese (35.8%), nourished nonobese (21.4%), and nourished obese (9.9%, P<0.001). Kaplan-Meier curves demonstrated least favorable survival in malnourished nonobese group, followed by malnourished obese, nourished nonobese, and nourished obese. With nourished nonobese group as the reference, malnourished nonobese had higher all-cause mortality (hazard ratio, 1.46 [95% CI, 1.10-1.96], P=0.010), but only a nonsignificant increase in mortality was observed in the malnourished obese (hazard ratio, 1.31 [95% CI, 0.94-1.83], P=0.112).

Conclusions: Among AMI patients, malnutrition is prevalent even in the obese. Compared to nourished patients, malnourished AMI patients have a more unfavorable prognosis especially in those with severe malnutrition regardless of obesity status, but long-term survival is the most favorable among nourished obese patients.

背景:营养不良的双重负担,即营养不良和肥胖的共存,是一个日益严重的全球健康问题。本研究探讨肥胖和营养不良对急性心肌梗死(AMI)患者的综合影响。方法:回顾性研究2014年1月至2021年3月在新加坡一家有经皮冠状动脉介入治疗能力的医院就诊的AMI患者。患者被分为以下几组:(1)营养非肥胖,(2)营养非肥胖,(3)营养肥胖,(4)营养不良肥胖。肥胖和营养不良分别根据世界卫生组织定义(体重指数≥27.5 kg/m2)和控制营养状况评分进行定义。主要结局为全因死亡率。结合年龄、性别、急性心肌梗死类型、既往急性心肌梗死、射血分数和慢性肾脏疾病等因素,采用Cox回归检验合并肥胖和营养状况与死亡率之间的关系。构建了全因死亡率的Kaplan-Meier曲线。结果:纳入AMI患者1829例,男性75.7%,平均年龄66岁。超过75%的患者营养不良。大多数是营养不良非肥胖(57.7%),其次是营养不良肥胖(18.8%)、营养非肥胖(16.9%)和营养肥胖(6.6%)。营养不良非肥胖者的全因死亡率最高(38.6%),其次是营养不良肥胖者(35.8%)、营养不良非肥胖者(21.4%)和营养肥胖者(9.9%,PP=0.010),但营养不良肥胖者的死亡率没有显著增加(风险比为1.31 [95% CI, 0.94-1.83], P=0.112)。结论:在急性心肌梗死患者中,即使是肥胖者也普遍存在营养不良。与营养不良的AMI患者相比,营养不良的AMI患者预后更不利,尤其是严重营养不良的AMI患者,与肥胖状况无关,但营养不良的AMI患者长期生存最有利。
{"title":"Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study.","authors":"Gwyneth Kong,&nbsp;Audrey Zhang,&nbsp;Bryan Chong,&nbsp;Jieyu Lim,&nbsp;Shankar Kannan,&nbsp;Yip Han Chin,&nbsp;Cheng Han Ng,&nbsp;Chaoxing Lin,&nbsp;Chin Meng Khoo,&nbsp;Mark Muthiah,&nbsp;Mayank Dalakoti,&nbsp;William Kristanto,&nbsp;Yibin Wang,&nbsp;William Kong,&nbsp;Kian Keong Poh,&nbsp;Ping Chai,&nbsp;Roger Foo,&nbsp;Mark Yan-Yee Chan,&nbsp;Poay-Huan Loh,&nbsp;Nicholas W S Chew","doi":"10.1161/CIRCOUTCOMES.122.009340","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.122.009340","url":null,"abstract":"<p><strong>Background: </strong>The double burden of malnutrition, described as the coexistence of malnutrition and obesity, is a growing global health issue. This study examines the combined effects of obesity and malnutrition on patients with acute myocardial infarction (AMI).</p><p><strong>Methods: </strong>Patients presenting with AMI to a percutaneous coronary intervention-capable hospital in Singapore between January 2014 and March 2021 were retrospectively studied. Patients were stratified into the following: (1) nourished nonobese, (2) malnourished nonobese, (3) nourished obese, and (4) malnourished obese. Obesity and malnutrition were defined according to the World Health Organization definition (body mass index ≥27.5 kg/m<sup>2</sup>) and Controlling Nutritional Status score, respectively. The primary outcome was all-cause mortality. The association between combined obesity and nutritional status with mortality was examined using Cox regression, adjusted for age, sex, AMI type, previous AMI, ejection fraction, and chronic kidney disease. Kaplan-Meier curves for all-cause mortality were constructed.</p><p><strong>Results: </strong>The study included 1829 AMI patients, of which 75.7% were male and mean age was 66 years. Over 75% of patients were malnourished. Majority were malnourished nonobese (57.7%), followed by malnourished obese (18.8%), nourished nonobese (16.9%), and nourished obese (6.6%). Malnourished nonobese had highest all-cause mortality (38.6%), followed by the malnourished obese (35.8%), nourished nonobese (21.4%), and nourished obese (9.9%, <i>P</i><0.001). Kaplan-Meier curves demonstrated least favorable survival in malnourished nonobese group, followed by malnourished obese, nourished nonobese, and nourished obese. With nourished nonobese group as the reference, malnourished nonobese had higher all-cause mortality (hazard ratio, 1.46 [95% CI, 1.10-1.96], <i>P</i>=0.010), but only a nonsignificant increase in mortality was observed in the malnourished obese (hazard ratio, 1.31 [95% CI, 0.94-1.83], <i>P</i>=0.112).</p><p><strong>Conclusions: </strong>Among AMI patients, malnutrition is prevalent even in the obese. Compared to nourished patients, malnourished AMI patients have a more unfavorable prognosis especially in those with severe malnutrition regardless of obesity status, but long-term survival is the most favorable among nourished obese patients.</p>","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 4","pages":"e009340"},"PeriodicalIF":6.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9484574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Discrimination Experiences and All-Cause and Cardiovascular Mortality: Multi-Ethnic Study of Atherosclerosis. 动脉粥样硬化的多种族研究:歧视经验、全因死亡率和心血管死亡率。
IF 6.9 2区 医学 Pub Date : 2023-04-01 DOI: 10.1161/CIRCOUTCOMES.122.009697
Wayne R Lawrence, Gieira S Jones, Jarrett A Johnson, Koya P Ferrell, Jacquita N Johnson, Meredith S Shiels, Ana V Diez Roux, Allana T Forde

Background: Epidemiologic studies have documented the associations between experiences of discrimination and adverse health outcomes. However, the relationship between discrimination and mortality, and the factors that may moderate this relationship are not well understood. This study examined whether lifetime and everyday discrimination were associated with all-cause and cardiovascular mortality and whether these associations differed by race and ethnicity, gender, and racial and ethnic residential segregation.

Methods: The study included 1633 Black, 1403 Hispanic/Latino, and 2473 White participants aged 45 to 84 years from the Multi-Ethnic Study of Atherosclerosis, enrolled from 2000 to 2002 and followed across 5 exams (2002-2018). Discrimination was measured using the lifetime discrimination (major experiences of unfair treatment) and everyday discrimination (day-to-day experiences of unfair treatment) scales. Racial and ethnic residential segregation was measured using the Gi* statistic. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% CIs, adjusting for sociodemographic characteristics, health behaviors, and clinical risk factors.

Results: Each increase in reports of lifetime discrimination was associated with increased all-cause (HR, 1.06 [95% CI, 1.00-1.11]) and cardiovascular (HR, 1.15 [95% CI, 1.04-1.27]) mortality, adjusting for sociodemographic factors, health behaviors, and clinical risk factors. Associations between lifetime discrimination and cardiovascular mortality were observed across all racial and ethnic groups but were strongest and only statistically significant among Black participants (HR, 1.18 [95% CI, 1.02-1.37]). Additionally, in the fully adjusted model, each increase in reports of everyday discrimination was strongly associated with increased cardiovascular mortality (HR, 1.21 [95% CI, 1.03-1.43]). Associations for lifetime and everyday discrimination with all-cause and cardiovascular mortality were not modified by race and ethnicity, gender, or racial and ethnic residential segregation.

Conclusions: These findings suggest that experiences of discrimination are associated with increased all-cause and cardiovascular mortality.

背景:流行病学研究证明了歧视经历与不良健康结果之间的关联。然而,歧视与死亡率之间的关系以及可能缓和这种关系的因素尚未得到很好的理解。本研究调查了终生和日常歧视是否与全因死亡率和心血管死亡率相关,以及这些关联是否因种族和民族、性别、种族和民族居住隔离而异。方法:该研究包括来自动脉粥样硬化多种族研究的1633名黑人、1403名西班牙裔/拉丁裔和2473名年龄在45至84岁之间的白人参与者,他们于2000年至2002年入组,并进行了5次检查(2002年至2018年)。歧视是用终身歧视(主要不公平待遇经历)和日常歧视(每天不公平待遇经历)量表来衡量的。种族和民族居住隔离是用Gi*统计来衡量的。Cox比例风险回归用于估计风险比(hr)和95% ci,调整社会人口统计学特征、健康行为和临床危险因素。结果:在调整了社会人口因素、健康行为和临床危险因素后,终生歧视报告的每增加都与全因死亡率(HR, 1.06 [95% CI, 1.00-1.11])和心血管死亡率(HR, 1.15 [95% CI, 1.04-1.27])的增加相关。在所有种族和民族中都观察到终生歧视与心血管死亡率之间的关联,但在黑人参与者中最强且仅具有统计学意义(HR, 1.18 [95% CI, 1.02-1.37])。此外,在完全调整模型中,日常歧视报告的每增加都与心血管死亡率的增加密切相关(HR, 1.21 [95% CI, 1.03-1.43])。终生和日常歧视与全因死亡率和心血管死亡率的关联不受种族和民族、性别或种族和民族居住隔离的影响。结论:这些发现表明,歧视经历与全因死亡率和心血管死亡率增加有关。
{"title":"Discrimination Experiences and All-Cause and Cardiovascular Mortality: Multi-Ethnic Study of Atherosclerosis.","authors":"Wayne R Lawrence,&nbsp;Gieira S Jones,&nbsp;Jarrett A Johnson,&nbsp;Koya P Ferrell,&nbsp;Jacquita N Johnson,&nbsp;Meredith S Shiels,&nbsp;Ana V Diez Roux,&nbsp;Allana T Forde","doi":"10.1161/CIRCOUTCOMES.122.009697","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.122.009697","url":null,"abstract":"<p><strong>Background: </strong>Epidemiologic studies have documented the associations between experiences of discrimination and adverse health outcomes. However, the relationship between discrimination and mortality, and the factors that may moderate this relationship are not well understood. This study examined whether lifetime and everyday discrimination were associated with all-cause and cardiovascular mortality and whether these associations differed by race and ethnicity, gender, and racial and ethnic residential segregation.</p><p><strong>Methods: </strong>The study included 1633 Black, 1403 Hispanic/Latino, and 2473 White participants aged 45 to 84 years from the Multi-Ethnic Study of Atherosclerosis, enrolled from 2000 to 2002 and followed across 5 exams (2002-2018). Discrimination was measured using the lifetime discrimination (major experiences of unfair treatment) and everyday discrimination (day-to-day experiences of unfair treatment) scales. Racial and ethnic residential segregation was measured using the <i>Gi*</i> statistic. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% CIs, adjusting for sociodemographic characteristics, health behaviors, and clinical risk factors.</p><p><strong>Results: </strong>Each increase in reports of lifetime discrimination was associated with increased all-cause (HR, 1.06 [95% CI, 1.00-1.11]) and cardiovascular (HR, 1.15 [95% CI, 1.04-1.27]) mortality, adjusting for sociodemographic factors, health behaviors, and clinical risk factors. Associations between lifetime discrimination and cardiovascular mortality were observed across all racial and ethnic groups but were strongest and only statistically significant among Black participants (HR, 1.18 [95% CI, 1.02-1.37]). Additionally, in the fully adjusted model, each increase in reports of everyday discrimination was strongly associated with increased cardiovascular mortality (HR, 1.21 [95% CI, 1.03-1.43]). Associations for lifetime and everyday discrimination with all-cause and cardiovascular mortality were not modified by race and ethnicity, gender, or racial and ethnic residential segregation.</p><p><strong>Conclusions: </strong>These findings suggest that experiences of discrimination are associated with increased all-cause and cardiovascular mortality.</p>","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 4","pages":"e009697"},"PeriodicalIF":6.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/0f/hcq-16-e009697.PMC10106108.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9854433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Quantifying Blood Pressure Visit-to-Visit Variability in the Real-World Setting: A Retrospective Cohort Study. 在真实世界环境中量化血压就诊变异性:回顾性队列研究
IF 6.9 2区 医学 Pub Date : 2023-04-01 Epub Date: 2023-03-08 DOI: 10.1161/CIRCOUTCOMES.122.009258
Yuan Lu, George C Linderman, Shiwani Mahajan, Yuntian Liu, Chenxi Huang, Rohan Khera, Bobak J Mortazavi, Erica S Spatz, Harlan M Krumholz

Background: Visit-to-visit variability (VVV) in blood pressure values has been reported in clinical studies. However, little is known about VVV in clinical practice and whether it is associated with patient characteristics in real-world setting.

Methods: We conducted a retrospective cohort study to quantify VVV in systolic blood pressure (SBP) values in a real-world setting. We included adults (age ≥18 years) with at least 2 outpatient visits between January 1, 2014 and October 31, 2018 from Yale New Haven Health System. Patient-level measures of VVV included SD and coefficient of variation of a given patient's SBP across visits. We calculated patient-level VVV overall and by patient subgroups. We further developed a multilevel regression model to assess the extent to which VVV in SBP was explained by patient characteristics.

Results: The study population included 537 218 adults, with a total of 7 721 864 SBP measurements. The mean age was 53.4 (SD 19.0) years, 60.4% were women, 69.4% were non-Hispanic White, and 18.1% were on antihypertensive medications. Patients had a mean body mass index of 28.4 (5.9) kg/m2 and 22.6%, 8.0%, 9.7%, and 5.6% had a history of hypertension, diabetes, hyperlipidemia, and coronary artery disease, respectively. The mean number of visits per patient was 13.3, over an average period of 2.4 years. The mean (SD) intraindividual SD and coefficient of variation of SBP across visits were 10.6 (5.1) mm Hg and 0.08 (0.04). These measures of blood pressure variation were consistent across patient subgroups defined by demographic characteristics and medical history. In the multivariable linear regression model, only 4% of the variance in absolute standardized difference was attributable to patient characteristics.

Conclusions: The VVV in real-world practice poses challenges for management of patients with hypertension based on blood pressure readings in outpatient settings and suggest the need to go beyond episodic clinic evaluation.

背景:临床研究报告了血压值的就诊变异性(VVV)。然而,人们对临床实践中的 VVV 及其是否与真实世界中的患者特征相关却知之甚少:我们进行了一项回顾性队列研究,以量化真实世界环境中收缩压 (SBP) 值的 VVV。我们纳入了耶鲁大学纽黑文卫生系统在 2014 年 1 月 1 日至 2018 年 10 月 31 日期间至少有 2 次门诊就诊的成年人(年龄≥18 岁)。患者水平的 VVV 测量包括给定患者各次就诊时 SBP 的 SD 和变异系数。我们计算了患者层面的总体 VVV 以及患者亚组的 VVV。我们进一步建立了一个多层次回归模型,以评估患者特征对 SBP 变异的解释程度:研究对象包括 537 218 名成年人,共进行了 7 721 864 次 SBP 测量。平均年龄为 53.4 岁(SD 19.0),60.4% 为女性,69.4% 为非西班牙裔白人,18.1% 正在服用抗高血压药物。患者的平均体重指数为 28.4 (5.9) kg/m2,分别有 22.6%、8.0%、9.7% 和 5.6% 的患者有高血压、糖尿病、高脂血症和冠心病病史。每位患者的平均就诊次数为 13.3 次,平均就诊时间为 2.4 年。各次就诊时 SBP 的个体内平均值(SD)和变异系数分别为 10.6 (5.1) mm Hg 和 0.08 (0.04)。在根据人口统计学特征和病史定义的患者亚组中,这些血压变化测量值是一致的。在多变量线性回归模型中,患者特征仅占绝对标准化差异变异的 4%:真实世界中的 VVV 给根据门诊血压读数管理高血压患者带来了挑战,并表明有必要超越偶发的门诊评估。
{"title":"Quantifying Blood Pressure Visit-to-Visit Variability in the Real-World Setting: A Retrospective Cohort Study.","authors":"Yuan Lu, George C Linderman, Shiwani Mahajan, Yuntian Liu, Chenxi Huang, Rohan Khera, Bobak J Mortazavi, Erica S Spatz, Harlan M Krumholz","doi":"10.1161/CIRCOUTCOMES.122.009258","DOIUrl":"10.1161/CIRCOUTCOMES.122.009258","url":null,"abstract":"<p><strong>Background: </strong>Visit-to-visit variability (VVV) in blood pressure values has been reported in clinical studies. However, little is known about VVV in clinical practice and whether it is associated with patient characteristics in real-world setting.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study to quantify VVV in systolic blood pressure (SBP) values in a real-world setting. We included adults (age ≥18 years) with at least 2 outpatient visits between January 1, 2014 and October 31, 2018 from Yale New Haven Health System. Patient-level measures of VVV included SD and coefficient of variation of a given patient's SBP across visits. We calculated patient-level VVV overall and by patient subgroups. We further developed a multilevel regression model to assess the extent to which VVV in SBP was explained by patient characteristics.</p><p><strong>Results: </strong>The study population included 537 218 adults, with a total of 7 721 864 SBP measurements. The mean age was 53.4 (SD 19.0) years, 60.4% were women, 69.4% were non-Hispanic White, and 18.1% were on antihypertensive medications. Patients had a mean body mass index of 28.4 (5.9) kg/m<sup>2</sup> and 22.6%, 8.0%, 9.7%, and 5.6% had a history of hypertension, diabetes, hyperlipidemia, and coronary artery disease, respectively. The mean number of visits per patient was 13.3, over an average period of 2.4 years. The mean (SD) intraindividual SD and coefficient of variation of SBP across visits were 10.6 (5.1) mm Hg and 0.08 (0.04). These measures of blood pressure variation were consistent across patient subgroups defined by demographic characteristics and medical history. In the multivariable linear regression model, only 4% of the variance in absolute standardized difference was attributable to patient characteristics.</p><p><strong>Conclusions: </strong>The VVV in real-world practice poses challenges for management of patients with hypertension based on blood pressure readings in outpatient settings and suggest the need to go beyond episodic clinic evaluation.</p>","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 4","pages":"e009258"},"PeriodicalIF":6.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9537446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Outcomes Following Behavioral Weight Management Programs: Worth the Weight. 行为体重管理项目的长期结果:体重值得。
IF 6.9 2区 医学 Pub Date : 2023-04-01 DOI: 10.1161/CIRCOUTCOMES.123.009965
Vishal N Rao, Neha J Pagidipati
{"title":"Long-Term Outcomes Following Behavioral Weight Management Programs: Worth the Weight.","authors":"Vishal N Rao,&nbsp;Neha J Pagidipati","doi":"10.1161/CIRCOUTCOMES.123.009965","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.123.009965","url":null,"abstract":"","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 4","pages":"e009965"},"PeriodicalIF":6.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487370/pdf/hcq-16-e009965.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10558888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Examination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance System. 更正:美国成年人高血压患病率和抗高血压药物使用的性别认同差异检查:来自行为风险因素监测系统的发现。
IF 6.9 2区 医学 Pub Date : 2023-04-01 DOI: 10.1161/HCQ.0000000000000116
{"title":"Correction to: Examination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance System.","authors":"","doi":"10.1161/HCQ.0000000000000116","DOIUrl":"https://doi.org/10.1161/HCQ.0000000000000116","url":null,"abstract":"","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 4","pages":"e000116"},"PeriodicalIF":6.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9317203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"It's Overwhelming With the Grief" A Qualitative Study of Families' Experiences When a Young Relative Dies of Sudden Cardiac Death. "悲痛欲绝"--一项关于年轻亲属心脏猝死时家庭经历的定性研究。
IF 6.9 2区 医学 Pub Date : 2023-04-01 Epub Date: 2023-04-04 DOI: 10.1161/CIRCOUTCOMES.122.009524
Katherine S Allan, Katherine L Mason, Jodi Garner, Katie N Dainty, Dirk Huyer, Kris Cunningham, Paul Dorian, Krystina B Lewis

Background: Sudden cardiac death (SCD) in younger individuals is frequently caused by heritable cardiac conditions. The unexpected nature of SCD leaves families with many unanswered questions and an insufficient understanding of the cause of death and their own risk for heritable disease. We explored the experiences of families of young SCD victims upon learning about their relative's cause of death and how they perceive their own risk for heritable cardiac conditions.

Methods: We conducted a qualitative descriptive study, by interviewing families of young (ages 12-45) SCD victims, who died between 2014 and 2018 from a heritable cardiac condition and were investigated by the Office of the Chief Coroner of Ontario, Canada. We used thematic analysis to analyze the transcripts.

Results: Between 2018 and 2020, we interviewed 19 family members, of which 10 were males and 9 were females, ages ranging from 21 to 65 (average 46.2±13.1). Four main themes were revealed, each representing a distinct time period that families experience along a trajectory: (1) interactions between bereaved family and others, in particular coroners, shaped their search for answers about their relative's cause of death, with the types, formats, and timing of communication varying by case; (2) searching for answers and processing the cause of death; (3) incidental implications of the SCD event, such as financial strain and lifestyle changes contributed to cumulative stress; (4) receiving answers (or not) and moving forward.

Conclusions: Families rely on communication with others, yet the type, formats, and timing of information received varies, which can influence families' experiences of processing the death (and its cause), their perceived risk and their decision to pursue cascade screening. These results may provide key insights for the interprofessional health care team responsible for the delivery and communication of the cause of death to families of SCD victims.

背景:年轻人的心脏性猝死(SCD)通常是由遗传性心脏疾病引起的。SCD 的突发性给家属留下了许多未解之谜,他们对死因和自身患遗传性疾病的风险认识不足。我们探讨了年轻的 SCD 患者家属在了解其亲属死因时的经历,以及他们如何看待自己患遗传性心脏病的风险:我们进行了一项定性描述性研究,采访了 2014 年至 2018 年期间死于遗传性心脏病并接受加拿大安大略省首席验尸官办公室调查的年轻(12-45 岁)SCD 受害者的家属。我们采用主题分析法对笔录进行了分析:2018 年至 2020 年间,我们采访了 19 名家庭成员,其中男性 10 人,女性 9 人,年龄从 21 岁至 65 岁(平均 46.2±13.1)岁。访谈揭示了四大主题,每个主题都代表了家属在不同时间段经历的轨迹:(1)丧亲之痛的家属与他人(尤其是验尸官)之间的互动影响了他们对亲属死因答案的探寻,沟通的类型、形式和时间因个案而异;(2)探寻答案并处理死因;(3)SCD 事件的附带影响,如经济压力和生活方式的改变导致压力累积;(4)获得答案(或未获得答案)并继续前行:家庭依赖于与他人的沟通,然而所获得信息的类型、形式和时间各不相同,这可能会影响家庭处理死亡(及其原因)的经验、他们所感知的风险以及他们进行级联筛查的决定。这些结果可为负责向 SCD 患者家属提供死因信息并进行沟通的跨专业医疗团队提供重要启示。
{"title":"\"<i>It's Overwhelming With the Grief\"</i> A Qualitative Study of Families' Experiences When a Young Relative Dies of Sudden Cardiac Death.","authors":"Katherine S Allan, Katherine L Mason, Jodi Garner, Katie N Dainty, Dirk Huyer, Kris Cunningham, Paul Dorian, Krystina B Lewis","doi":"10.1161/CIRCOUTCOMES.122.009524","DOIUrl":"10.1161/CIRCOUTCOMES.122.009524","url":null,"abstract":"<p><strong>Background: </strong>Sudden cardiac death (SCD) in younger individuals is frequently caused by heritable cardiac conditions. The unexpected nature of SCD leaves families with many unanswered questions and an insufficient understanding of the cause of death and their own risk for heritable disease. We explored the experiences of families of young SCD victims upon learning about their relative's cause of death and how they perceive their own risk for heritable cardiac conditions.</p><p><strong>Methods: </strong>We conducted a qualitative descriptive study, by interviewing families of young (ages 12-45) SCD victims, who died between 2014 and 2018 from a heritable cardiac condition and were investigated by the Office of the Chief Coroner of Ontario, Canada. We used thematic analysis to analyze the transcripts.</p><p><strong>Results: </strong>Between 2018 and 2020, we interviewed 19 family members, of which 10 were males and 9 were females, ages ranging from 21 to 65 (average 46.2±13.1). Four main themes were revealed, each representing a distinct time period that families experience along a trajectory: (1) interactions between bereaved family and others, in particular coroners, shaped their search for answers about their relative's cause of death, with the types, formats, and timing of communication varying by case; (2) searching for answers and processing the cause of death; (3) incidental implications of the SCD event, such as financial strain and lifestyle changes contributed to cumulative stress; (4) receiving answers (or not) and moving forward.</p><p><strong>Conclusions: </strong>Families rely on communication with others, yet the type, formats, and timing of information received varies, which can influence families' experiences of processing the death (and its cause), their perceived risk and their decision to pursue cascade screening. These results may provide key insights for the interprofessional health care team responsible for the delivery and communication of the cause of death to families of SCD victims.</p>","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 4","pages":"e009524"},"PeriodicalIF":6.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9488167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes From Cardiovascular Disease Extend Beyond Traditional Risk Factors: We Are What We Eat (or Don't Eat). 心血管疾病的后果超出了传统的风险因素:我们吃什么(或不吃什么)。
IF 6.9 2区 医学 Pub Date : 2023-04-01 DOI: 10.1161/CIRCOUTCOMES.123.009886
Eric J Brandt
{"title":"Outcomes From Cardiovascular Disease Extend Beyond Traditional Risk Factors: We Are What We Eat (or Don't Eat).","authors":"Eric J Brandt","doi":"10.1161/CIRCOUTCOMES.123.009886","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.123.009886","url":null,"abstract":"","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 4","pages":"e009886"},"PeriodicalIF":6.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9484573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updating the Accuracy of Administrative Claims for Identifying Left Ventricular Ejection Fraction Among Patients With Heart Failure. 更新行政索赔在识别心力衰竭患者左心室射血分数方面的准确性。
IF 6.9 2区 医学 Pub Date : 2023-04-01 Epub Date: 2023-03-16 DOI: 10.1161/CIRCOUTCOMES.122.008919
Alexander T Sandhu, Jimmy Zheng, Megan Skye, Paul A Heidenreich
{"title":"Updating the Accuracy of Administrative Claims for Identifying Left Ventricular Ejection Fraction Among Patients With Heart Failure.","authors":"Alexander T Sandhu, Jimmy Zheng, Megan Skye, Paul A Heidenreich","doi":"10.1161/CIRCOUTCOMES.122.008919","DOIUrl":"10.1161/CIRCOUTCOMES.122.008919","url":null,"abstract":"","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 4","pages":"e008919"},"PeriodicalIF":6.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9484601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Should We Talk With Families After a Sudden Cardiac Death? 心脏病猝死后,我们应该如何与家属沟通?
IF 6.9 2区 医学 Pub Date : 2023-04-01 Epub Date: 2023-04-04 DOI: 10.1161/CIRCOUTCOMES.123.009841
Kimberly C Dukes, Saket Girotra
{"title":"How Should We Talk With Families After a Sudden Cardiac Death?","authors":"Kimberly C Dukes, Saket Girotra","doi":"10.1161/CIRCOUTCOMES.123.009841","DOIUrl":"10.1161/CIRCOUTCOMES.123.009841","url":null,"abstract":"","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 4","pages":"e009841"},"PeriodicalIF":6.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10776025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9482375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Total Occlusion PCI and Optimal Medical Therapy: Are We Still Putting the Cart Before the Horse? 慢性全闭塞PCI和最佳药物治疗:我们是否仍然本末倒置?
IF 6.9 2区 医学 Pub Date : 2023-03-01 DOI: 10.1161/CIRCOUTCOMES.122.009604
Allison L Tsao, William E Boden
{"title":"Chronic Total Occlusion PCI and Optimal Medical Therapy: Are We Still Putting the Cart Before the Horse?","authors":"Allison L Tsao,&nbsp;William E Boden","doi":"10.1161/CIRCOUTCOMES.122.009604","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.122.009604","url":null,"abstract":"","PeriodicalId":10301,"journal":{"name":"Circulation. Cardiovascular Quality and Outcomes","volume":"16 3","pages":"e009604"},"PeriodicalIF":6.9,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9536958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Circulation. Cardiovascular Quality and Outcomes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1